Literature DB >> 10147034

The changing healthcare environment: socioeconomic evaluation of drug therapy.

D B Evans.   

Abstract

Mesh：

Year:  1992        PMID： 10147034     DOI： 10.2165/00019053-199201010-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  8 in total

1.  Economic analysis as an aid to subsidisation decisions: the development of Australian guidelines for pharmaceuticals.

Authors:  D Henry
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

2.  Economic evaluation of pharmaceuticals: science or marketing?

Authors:  M F Drummond
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

3.  Cost of innovation in the pharmaceutical industry.

Authors:  J A DiMasi; R W Hansen; H G Grabowski; L Lasagna
Journal:  J Health Econ       Date:  1991-07       Impact factor: 3.883

4.  The costs of compliance with the 1962 FDA amendments.

Authors:  D Dranove
Journal:  J Health Econ       Date:  1991-07       Impact factor: 3.883

5.  Farewell to promoting goodbuys?

Authors: 
Journal:  Lancet       Date:  1991-08-17       Impact factor: 79.321

6.  The Netherlands introduces some competition into the health services.

Authors:  A J Schrijvers
Journal:  JAMA       Date:  1991 Oct 23-30       Impact factor: 56.272

7.  Oregon's plan. Should it be approved?

Authors:  D M Eddy
Journal:  JAMA       Date:  1991-11-06       Impact factor: 56.272

8.  Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.

Authors:  A L Hillman; J M Eisenberg; M V Pauly; B S Bloom; H Glick; B Kinosian; J S Schwartz
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245
  8 in total
  4 in total

1.  Comparison of prescribing habits of general practitioners in The Netherlands versus England and Wales.

Authors:  F M Hull; R F Westerman; R Jonkers
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

Review 2.  Expanding the role of pharmacists in pharmacoeconomics: why and how?

Authors:  L A Sanchez
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

3.  Pharmaceutical formulation and healthcare expenditures.

Authors:  D A Sclar; T L Skaer
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

4.  Full-cost determination of different levels of care in the intensive care unit. An activity-based costing approach.

Authors:  J J Doyle; J P Casciano; S R Arikian; J Mauskopf; J E Paul
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.